(Q34207970)
Statements
1 reference
CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity (English)
1 reference
Jonathan M Friedman
1 reference
Keiichi Sakakibara
1 reference
Naoya Saito
1 reference
Takuji Sato
1 reference
Atsushi Suzuki
1 reference
Yoko Hasegawa
1 reference
Donald W Kufe
1 reference
Daniel D Vonhoff
1 reference
Tadahiko Iwami
1 reference
Takumi Kawabe
1 reference
12 August 2011
1 reference
1 reference
118
1 reference
14
1 reference
3922-3931
1 reference
Identifiers
1 reference
1 reference